Anastrozole
- Product NDC
- 72789-008
- Requested package NDC
- 72789-008-90
- 11-digit product format
- 727890008
- Labeler code
- 72789
- Product ID
- 72789-008_3766532d-5b61-f994-e063-6294a90aa731
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Anastrozole
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA090568
- Marketing category
- ANDA
- Marketing start
- 2010-06-22
- Substance
- ANASTROZOLE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090568-001 | ANASTROZOLE | ANASTROZOLE | 1MG | TABLET / ORAL | AB | 2010-06-28 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A090568-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090568-001 | ANASTROZOLE | 1MG | TABLET / ORAL | AB | 2010-06-28 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090568-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anastrozole | ANASTROZOLE | PD-Rx Pharmaceuticals, Inc. | aabd8f88-2b52-4d43-8dc6-61605988c4dc | 2026-07-07 | Warnings, Adverse reactions | 090568 ANDA090568 72789-008-90 72789-008 72789000890 |
| Anastrozole | ANASTROZOLE | Asclemed USA, Inc. | b964f555-25d2-47ad-8942-f195f062445c | 2026-02-14 | Warnings, Adverse reactions | 090568 ANDA090568 |
| Anastrozole | ANASTROZOLE | Accord Healthcare Inc. | 03586c40-eb32-45c5-beb7-6762a6b78790 | 2026-02-11 | Warnings, Adverse reactions | 090568 ANDA090568 |
| Anastrozole | ANASTROZOLE | NuCare Pharmaceuticals,Inc. | e3b5fc92-9189-6944-e053-2a95a90a1c9f | 2025-04-03 | Warnings, Adverse reactions | 090568 ANDA090568 |
| ANASTROZOLE | ANASTROZOLE | Direct_Rx | f37db328-bb81-9df9-e053-2a95a90a6f43 | 2025-01-22 | Warnings, Adverse reactions | 090568 ANDA090568 |
| Anastrozole | ANASTROZOLE | NuCare Pharmaceuticals,Inc. | 5a2d5052-95ce-d103-e053-2991aa0aa4be | 2024-12-26 | Warnings, Adverse reactions | 090568 ANDA090568 |
| Anastrozole | ANASTROZOLE | Bryant Ranch Prepack | 19251d0b-279a-49f5-99b2-0e74d7cca479 | 2024-08-22 | Warnings, Adverse reactions | 090568 ANDA090568 |
| Anastrozole | ANASTROZOLE | NuCare Pharmaceuticals,Inc. | a0acddf1-a973-bf37-e053-2995a90a0bd5 | 2024-06-20 | Warnings, Adverse reactions | 090568 ANDA090568 |
| Anastrozole | ANASTROZOLE | A-S Medication Solutions | 03fb3108-1856-466d-bf88-0eac96139551 | 2024-06-05 | Warnings, Adverse reactions | 090568 ANDA090568 |
| Anastrozole | ANASTROZOLE | NuCare Pharmaceuticals,Inc. | ef6c9f7c-a1b0-3fee-e053-2995a90ab2c4 | 2024-04-05 | Warnings, Adverse reactions | 090568 ANDA090568 |
| Anastrozole | ANASTROZOLE | Proficient Rx LP | c7a36fd8-530e-4c63-97d5-0f80fab5880e | 2023-05-01 | Warnings, Adverse reactions | 090568 ANDA090568 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Anastrozole
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ANASTROZOLE | 1 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2Z07MYW1AZ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 199224 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| aabd8f88-2b52-4d43-8dc6-61605988c4dc | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 9495fd23-86bb-d8f7-ae78-6dfe2f4dae2d | Product name | 3 | 20210204 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72789-008-15 | Anastrozole | 15 in 1 BOTTLE, PLASTIC | TABLET | 15 | 17 | |
| 72789-008-90 | Anastrozole | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 17 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72789-008-15 | EA - Each | 72789-008 | a470038e-0f13-4ea7-8a6c-15907bd4194c | 1 | 2019-10-07 |
| 72789-008-90 | EA - Each | 72789-008 | b96f6248-f453-4d62-9e58-8655c5d85620 | 1 | 2020-05-08 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 199224 | anastrozole 1 MG Oral Tablet | PSN | aabd8f88-2b52-4d43-8dc6-61605988c4dc | 17 |
| 199224 | anastrozole 1 MG Oral Tablet | SCD | aabd8f88-2b52-4d43-8dc6-61605988c4dc | 17 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 72789-008-90 | 72789000890 | 90 TABLET in 1 BOTTLE, PLASTIC (72789-008-90) | 90 tablet | 2020-03-06 | 0000-00-00 | No | No | Current |